[Vasopressors and inotropes: use in paediatrics]

Area of Science:

• Cardiovascular Pharmacology
• Pediatric Critical Care Medicine

Background:

• The cardiovascular system ensures tissue oxygen and nutrient delivery, crucial for cell metabolism.
• Vasoactive substances regulate vascular tone and myocardial function, offering benefits in pediatric heart failure and shock.
• However, their misuse can lead to adverse effects, increased mortality, and arrhythmias.

Purpose of the Study:

• To review the pharmacology of inotropic and vasopressor agents.
• To describe the clinical applications of these agents in critically ill pediatric patients.
• To highlight the importance of understanding their mechanisms to minimize harm.

Main Methods:

• Literature review of pharmacological and clinical data.
• Analysis of inotropic and vasopressor agents' effects in pediatric critical care.
• Synthesis of information on indications, mechanisms, and adverse effects.

Main Results:

• Inotropic and vasopressor agents are essential in managing pediatric cardiovascular compromise.
• Knowledge of their actions is critical to balance benefits against risks such as ischemia and arrhythmias.
• Optimal use requires careful consideration of drug mechanisms and patient condition.

Conclusions:

• A thorough understanding of inotropic and vasopressor pharmacology is essential for effective pediatric critical care.
• Minimizing adverse events requires precise application based on drug mechanisms and clinical indications.
• This review provides a foundation for optimizing the use of these agents in vulnerable pediatric populations.